Balyasny Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.6M | Buy |
153,436
+119,909
| +358% | +$63M | 0.12% | 159 |
|
|
2025
Q1 | $21.3M | Buy |
33,527
+4,736
| +16% | +$3M | 0.04% | 425 |
|
|
2024
Q4 | $20.5M | Buy |
28,791
+20,705
| +256% | +$14.7M | 0.03% | 496 |
|
|
2024
Q3 | $8.5M | Buy |
8,086
+610
| +8% | +$641K | 0.01% | 720 |
|
|
2024
Q2 | $7.86M | Sell |
7,476
-2,126
| -22% | -$2.23M | 0.01% | 700 |
|
|
2024
Q1 | $9.24M | Sell |
9,602
-32,391
| -77% | -$31.2M | 0.02% | 703 |
|
|
2023
Q4 | $36.9M | Buy |
41,993
+40,065
| +2,078% | +$35.2M | 0.07% | 267 |
|
|
2023
Q3 | $1.59M | Sell |
1,928
-665
| -26% | -$547K | ﹤0.01% | 1049 |
|
|
2023
Q2 | $1.86M | Buy |
+2,593
| New | +$1.86M | ﹤0.01% | 1045 |
|
|
2023
Q1 | – | Sell |
-33,457
| Closed | -$24.1M | – | 2564 |
|
|
2022
Q4 | $24.1M | Buy |
+33,457
| New | +$24.1M | 0.07% | 331 |
|
|
2022
Q3 | – | Sell |
-80,763
| Closed | -$47.7M | – | 2692 |
|
|
2022
Q2 | $47.7M | Buy |
+80,763
| New | +$47.7M | 0.16% | 123 |
|
|
2021
Q3 | – | Sell |
-66,919
| Closed | -$37.4M | – | 2013 |
|
|
2021
Q2 | $37.4M | Buy |
+66,919
| New | +$37.4M | 0.18% | 120 |
|
|
2020
Q4 | – | Sell |
-30,582
| Closed | -$17.1M | – | 1422 |
|
|
2020
Q3 | $17.1M | Buy |
+30,582
| New | +$17.1M | 0.13% | 204 |
|
|
2019
Q4 | – | Sell |
-176,027
| Closed | -$48.8M | – | 1297 |
|
|
2019
Q3 | $48.8M | Sell |
176,027
-83,020
| -32% | -$23M | 0.34% | 61 |
|
|
2019
Q2 | $81.1M | Buy |
259,047
+155,008
| +149% | +$48.5M | 0.52% | 26 |
|
|
2019
Q1 | $42.7M | Buy |
104,039
+57,867
| +125% | +$23.8M | 0.28% | 80 |
|
|
2018
Q4 | $17.2M | Buy |
46,172
+15,898
| +53% | +$5.94M | 0.12% | 221 |
|
|
2018
Q3 | $12.2M | Buy |
30,274
+21,238
| +235% | +$8.58M | 0.06% | 361 |
|
|
2018
Q2 | $3.12M | Sell |
9,036
-165,138
| -95% | -$57M | 0.01% | 664 |
|
|
2018
Q1 | $60M | Sell |
174,174
-30,383
| -15% | -$10.5M | 0.25% | 81 |
|
|
2017
Q4 | $76.9M | Buy |
+204,557
| New | +$76.9M | 0.24% | 88 |
|
|
2017
Q3 | – | Sell |
-58,357
| Closed | -$28.7M | – | 1811 |
|
|
2017
Q2 | $28.7M | Buy |
58,357
+18,857
| +48% | +$9.26M | 0.12% | 209 |
|
|
2017
Q1 | $15.3M | Buy |
+39,500
| New | +$15.3M | 0.07% | 316 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1259 |
|
|
2013
Q3 | – | Sell |
-29,750
| Closed | -$6.69M | – | 535 |
|
|
2013
Q2 | $6.69M | Buy |
+29,750
| New | +$6.69M | 0.11% | 165 |
|